51
|
Zhou J, Miyoshi N. A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects: reply. J Thromb Haemost 2017; 15:2081-2083. [PMID: 28799285 DOI: 10.1111/jth.13798] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J Zhou
- Cardiovascular and Metabolic Disease Clinical Development, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
| | - N Miyoshi
- End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan
| |
Collapse
|